These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
740 related items for PubMed ID: 19472365
1. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E. Fan J, Donkin J, Wellington C. Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365 [Abstract] [Full Text] [Related]
2. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, Laska E, Ehrlich ME, Walker LC, Mathews PM, Gandy S. J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [Abstract] [Full Text] [Related]
3. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade. Dolev I, Michaelson DM. Proc Natl Acad Sci U S A; 2004 Sep 21; 101(38):13909-14. PubMed ID: 15365176 [Abstract] [Full Text] [Related]
4. Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease. Donahue JE, Johanson CE. J Neuropathol Exp Neurol; 2008 Apr 21; 67(4):261-70. PubMed ID: 18379441 [Abstract] [Full Text] [Related]
5. Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease. Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Neurobiol Dis; 2002 Apr 21; 9(3):305-18. PubMed ID: 11950276 [Abstract] [Full Text] [Related]
6. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Ann Neurol; 2000 Jun 21; 47(6):739-47. PubMed ID: 10852539 [Abstract] [Full Text] [Related]
7. Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model. Mann KM, Thorngate FE, Katoh-Fukui Y, Hamanaka H, Williams DL, Fujita S, Lamb BT. Hum Mol Genet; 2004 Sep 01; 13(17):1959-68. PubMed ID: 15229191 [Abstract] [Full Text] [Related]
8. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. Thal DR, Capetillo-Zarate E, Schultz C, Rüb U, Saido TC, Yamaguchi H, Haass C, Griffin WS, Del Tredici K, Braak H, Ghebremedhin E. Acta Neuropathol; 2005 Nov 01; 110(5):459-71. PubMed ID: 16195918 [Abstract] [Full Text] [Related]
9. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Dodart JC, Marr RA, Koistinaho M, Gregersen BM, Malkani S, Verma IM, Paul SM. Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1211-6. PubMed ID: 15657137 [Abstract] [Full Text] [Related]
10. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition? Patil SP, Ballard R, Sanchez S, Osborn J, Santangelo D. Med Hypotheses; 2012 Apr 25; 78(4):494-6. PubMed ID: 22285195 [Abstract] [Full Text] [Related]
12. Why lipids are important for Alzheimer disease? Hirsch-Reinshagen V, Burgess BL, Wellington CL. Mol Cell Biochem; 2009 Jun 25; 326(1-2):121-9. PubMed ID: 19116777 [Abstract] [Full Text] [Related]
13. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo. Fagan AM, Holtzman DM. Microsc Res Tech; 2000 Aug 15; 50(4):297-304. PubMed ID: 10936884 [Abstract] [Full Text] [Related]
14. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR, Paul SM. Nat Med; 2004 Jul 15; 10(7):719-26. PubMed ID: 15195085 [Abstract] [Full Text] [Related]
15. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Lahiri DK, Sambamurti K, Bennett DA. Neurobiol Aging; 2004 Jul 15; 25(5):651-60. PubMed ID: 15172744 [Abstract] [Full Text] [Related]
16. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice. Thal DR, Larionov S, Abramowski D, Wiederhold KH, Van Dooren T, Yamaguchi H, Haass C, Van Leuven F, Staufenbiel M, Capetillo-Zarate E. Neurobiol Aging; 2007 Aug 15; 28(8):1221-30. PubMed ID: 16815595 [Abstract] [Full Text] [Related]
18. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid. Yamauchi K, Tozuka M, Nakabayashi T, Sugano M, Hidaka H, Kondo Y, Katsuyama T. J Neurosci Res; 1999 Oct 15; 58(2):301-7. PubMed ID: 10502286 [Abstract] [Full Text] [Related]
19. Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Bales KR. Neuropharmacology; 2010 Oct 15; 59(4-5):295-302. PubMed ID: 20079752 [Abstract] [Full Text] [Related]
20. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes. Utter S, Tamboli IY, Walter J, Upadhaya AR, Birkenmeier G, Pietrzik CU, Ghebremedhin E, Thal DR. J Neuropathol Exp Neurol; 2008 Sep 15; 67(9):842-56. PubMed ID: 18716559 [Abstract] [Full Text] [Related] Page: [Next] [New Search]